NAD+ Dosage, half-life & reference guide

Week by week.

What to expect in the first 8 weeks

Onset

Days to 2 weeks

Peak effect

2–6 weeks

Duration

2–6 week blocks

1. Day 1–14Community

   Refilling the cellular battery

   You're topping up the coenzyme your mitochondria run on. Commonly reported early on: a lift in daytime energy and clarity. A flush or queasiness usually tracks how fast it went in, and users find slower injections avoid it.

   The science

   NAD+ is the electron carrier in glycolysis, the TCA cycle, and oxidative phosphorylation, and the substrate sirtuins + PARPs require. Clinics and users commonly report the flush and nausea as a rate effect; no study has characterized it. Injectable NAD+ pharmacokinetics are short — it's rapidly metabolized and recycled through the salvage pathway.

   Sources

   • Rajman et al. (Cell Metabolism) (2018)

   Updated Sep 2026

2. Day 14–42Clinical

   Where steady-state effects show up

   If NAD+ is doing something for you, this is the window it tends to read — more durable energy, better tolerance of training, sometimes sharper focus. Track it honestly: energy and clarity are subjective, so a simple daily note beats relying on memory.

   The science

   Human RCTs on the oral precursors NMN and NR consistently raise blood NAD+ and improve some metabolic markers (e.g. insulin sensitivity in specific populations), though clinical endpoints remain modest. Whether injectable NAD+ reaches the same intracellular pools as precursor-driven salvage synthesis is not well characterized — the mechanism is plausible, the controlled human data is thin.

   Sources

   • Yoshino et al. (NMN, Science) (2021)
   • Martens et al. (NR RCT) (2018)

   Updated May 2026

3. Day 42–84Community

   A good point to take stock

   Community blocks often run 4–6 weeks then pause, but that cadence is convention, not an evidence-based endpoint. If energy or recovery moved, a break lets you see what holds without dosing. If nothing shifted, running longer probably won't change that — the decision is yours.

   The science

   No interventional trial defines an optimal duration or cycling schedule for injectable NAD+. Endogenous NAD+ is tightly regulated by the salvage pathway, so the body partly buffers exogenous input — an argument some make for intermittent rather than continuous use, though it's reasoning, not proven protocol.

   Sources

   • Covarrubias et al. (Nat Rev Mol Cell Biol) (2021)

   Updated May 2026

4. Any dayClinical

   What NAD+ is built on

   The biology is rock-solid: NAD+ powers energy metabolism and fuels sirtuins and DNA repair, and it declines with age in some tissues. The gap is the delivery form: the strong human trials are on oral NMN/NR precursors, while injected NAD+ rides mostly on mechanism and clinic experience. A 2026 head-to-head showed NMN and NR each roughly double blood NAD+ in two weeks; plain nicotinamide doesn't move it. Injected NAD+ has almost no controlled data: the one randomized trial gave low-dose IV NAD+ to heart-failure patients, not wellness dosing.

   The science

   Christen et al. (Nature Metabolism 2026) compared the precursors head-to-head: NMN and NR each ~doubled blood NAD+ over 14 days, while nicotinamide did not — the clearest precursor-efficacy comparison to date. NMN and NR have multiple RCTs showing they raise blood NAD+ with modest, population-specific clinical benefit. Injectable/IV NAD+ is widely used with only one small controlled trial: 180 patients with ischemic heart failure got 10 mg/day IV or placebo for 7 days, and ejection fraction was higher at one month (45.4% vs 42.4%; Yu 2025). Regulatory note: NMN was confirmed lawful as a dietary supplement by the FDA in late 2025 (Sept 29 and Dec 2), reversing the earlier uncertainty. Honest framing: high-confidence biology, high-confidence precursor pharmacology, lower-confidence injectable efficacy.

   Sources

   • Christen et al. (Nature Metabolism) (2026)
   • Yoshino et al. (Science) (2021)
   • Yu et al. (2025)

   Updated Sep 2026

5. With MOTS-c and EpitalonCommunity

   Why NAD+ pairs with mitochondrial peptides

   Different levers on the same system. NAD+ refills the coenzyme pool your mitochondria and sirtuins burn through; MOTS-c pushes the AMPK exercise-mimetic pathway. Complementary inputs to mitochondrial health rather than two versions of the same thing.

   The science

   NAD+ is a substrate (it gets consumed by sirtuins/PARPs); MOTS-c is a signal (it activates AMPK → PGC-1α → mitochondrial biogenesis). No published interaction data for the combo and no safety signal — the rationale is mechanistic complementarity, which is typically a sensible basis for stacking but isn't the same as proven synergy.

   Sources

   • Covarrubias et al. (2021)
   • Lee et al. (MOTS-c) (2015)

   Updated May 2026

Swipe for more ›

A typical run.

Safety.

Goes with.

• MOTS-c
• Epitalon
• Glutathione

Questions people ask.

Research.

Reference.

Cadence

Daily

Daily or EOD

Half-life

Minutes

Minutes (rapidly metabolized)

Research basis

●●● Emerging

Primarily preclinical / limited human data